Anti-AKT1 (Prognostic Marker for Neuroendocrine Tumors) Monoclonal Antibody(Clone: AKT1/2491), Clone: [AKT1/2491], Mouse

Catalog Number: ABI-36-2241
Article Name: Anti-AKT1 (Prognostic Marker for Neuroendocrine Tumors) Monoclonal Antibody(Clone: AKT1/2491), Clone: [AKT1/2491], Mouse
Biozol Catalog Number: ABI-36-2241
Supplier Catalog Number: 36-2241
Alternative Catalog Number: ABI-36-2241-100UG
Manufacturer: Abeomics
Host: Mouse
Category: Antikörper
Application: IHC, WB
Species Reactivity: Human
Immunogen: Recombinant fragment of human AKT1 protein (around aa 85-189) (exact sequence is proprietary)
Alternative Names: Oncogene AKT1, PKB, PKB-ALPHA, PRKBA, Protein Kinase B Alpha, Proto-oncogene c-Akt, RAC Alpha, RAC Serine/Threonine Protein Kinase, RAC-alpha serine/threonine-protein kinase, RAC-PK-alpha
Recognizes a protein of 62kDa, which is identified as AKT1The serine/threonine kinase Akt family contains several members, including Akt1 (also designated PKB or RacPK), Akt2 (also designated PKB tyrosine residues 740 and 751, which bind the subunit of the phosphatidylinositol 3-kinase (PI 3-kinase) complex. Activation of Akt1 by insulin or insulin-growth factor-1(IGF-1) results in phosphorylation of both Thr 308 and Ser 473. Akt proteins become phosphorylated and activated in insulin/IGF-1-stimulated cells by an upstream kinase(s), and the activation of Akt1 and Akt2 is inhibited by the PI kinase inhibitor wortmannin.
Clonality: Monoclonal
Clone Designation: [AKT1/2491]
NCBI: 207
UniProt: P31749
Application Dilute: Western Blot (1-2ug/ml), Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95C followed by cooling at RT for 20 minutes),